Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Nanosonics Limited ( (AU:NAN) ) has provided an update.
Nanosonics Limited has appointed William Haydon as the Regional President for North America, effective December 1, 2025, following the retirement of Ken Shaw. Haydon’s extensive experience in the medical device and healthcare technology sectors, particularly in infection prevention and endoscope reprocessing, aligns with Nanosonics’ strategic priorities as it prepares to commercialize its CORIS® platform, marking a significant step in its growth strategy.
The most recent analyst rating on (AU:NAN) stock is a Sell with a A$4.10 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.
More about Nanosonics Limited
Nanosonics Limited is a leader in infection prevention solutions, focusing on medical device reprocessing systems. The company is known for its innovative products like trophon® for ultrasound probe reprocessing and is preparing to launch the CORIS® platform for endoscope reprocessing.
Average Trading Volume: 687,759
Technical Sentiment Signal: Buy
Current Market Cap: A$1.31B
Find detailed analytics on NAN stock on TipRanks’ Stock Analysis page.